Alkermes (ALKS) Return on Capital Employed Growth (1y) (2012 - 2026)
Alkermes (ALKS) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | -1,932.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,932.00 |
| Mar 31, 2026 | -1,715.00 |
| Dec 31, 2025 | -1,203.00 |
| Sep 30, 2025 | 164.00 |
| Jun 30, 2025 | 452.00 |
| Mar 31, 2025 | -396.00 |
| Dec 31, 2024 | 110.00 |
| Sep 30, 2024 | -936.00 |
| Jun 30, 2024 | -274.00 |
| Mar 31, 2024 | 2,737.00 |
| Dec 31, 2023 | 2,496.00 |
| Sep 30, 2023 | 2,694.00 |
| Jun 30, 2023 | 1,756.00 |
| Mar 31, 2023 | -504.00 |
| Dec 31, 2022 | -677.00 |
| Sep 30, 2022 | 465.00 |
| Jun 30, 2022 | 669.00 |
| Mar 31, 2022 | 1,160.00 |
| Dec 31, 2021 | 1,397.00 |
| Sep 30, 2021 | 215.00 |